The majority are in the very early preclinical stage of development, but applications for regulatory approval have been ...
The gene-editing treatment will be available to certain patients with sickle cell disease in England as Vertex commits to collecting additional data.
Billie Eilish and Green Day kicked off the FireAid benefit concert in Los Angeles on Thursday night - a two-venue, five-hour ...
President Trump signed an executive order on the day of his inauguration that created doubts about the future of a program to ...
Fractyl Health is deprioritizing a type 2 diabetes trial in favor of a pivotal study of its endoscopy treatment Revita and ...
Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...
Vertex Pharmaceuticals (VRTX) stock gains as England opts to reimburse its CRSPR (CRSP)-partnered gene therapy Casgevy to ...
BOISE — Sen. Brandon Shippy, R-New Plymouth, is proposing to put a 10-year pause on certain types of vaccines that were used ...
The gene therapy Casgevy, which will now be offered to some patients in England, could help people live disease-free, experts ...
CAR T cell therapy is one of the most promising new cancer treatments to emerge in recent years. It involves removing a ...
NHS officials estimate that around 50 people a year will receive treatment now that it has been approved for use for certain ...
The company will use the funding to advance clinical trials for Tune-401, the epigenetic silencing drug for treating chronic ...